As of February 2026 Protalix BioTherapeutics has a market cap of โน17.24 Billion. This makes Protalix BioTherapeutics the world's 8627th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 31st, 2026 the market cap of Protalix BioTherapeutics was reported to be: